Regeneron Pharmaceuticals (NASDAQ:REGN) is one of the leaders in the ophthalmic disease therapeutics market. In this article, dear Seeking Alpha readers, I present five factors that explain why I ...

Johnson’s competition on Saturday was Knicks guard Jalen Brunson, Detroit Pistons guard Cade Cunningham, Cleveland Cavaliers guard Darius Garland, Miami Heat guard Tyler Herro, Golden State ...

All absentee ballots must be submitted by 5 p.m. on May 20. The district also used the board meeting to celebrate its Regeneron Science Talent Search finalist, Sandeep Sawhney, and to recognize ...

Regeneron is playing catch-up in the BCMAxCD3 class with Johnson & Johnson’s Tecvayli (teclistamab) and Pfizer’s Elrexfio (elranatamab), which have both been cleared by the FDA for relapsed or ...

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company’s products include EYLEA injection ...

a few days after a rival therapy from Johnson & Johnson was cleared in the EU for the same indication. It's also a key milestone for Regeneron, as Ordspono is the first bispecific antibody it has ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Regeneron has won a court ruling that will make it harder for U.S. authorities to win a lawsuit accusing it of paying illegal kickbacks through a charity to promote the use of its expensive eye ...